Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Multimodal complex treatment in advanced multiple sclerosis.]
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Genetically Modified Pig Models for Neurodegenerative Disorders.
Hypomyelinating disorders: An MRI approach.
Financial Incentives, Workplace Wellness Program Participation, and Utilization of Health Care Services and Spending.
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
Targeting the low-hanging fruit of neurodegeneration.
Acid-sensing ion channels promote the inflammation and migration of cultured rat microglia.
Leukotrienes induce the migration of Th17 cells.
Microglia and neuroprotection.
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Comments on "Role of intestinal microbiota in the development of multiple sclerosis".
Combined central and peripheral demyelination: A case description.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination.
A possible case of acute disseminated encephalomyelitis after Japanese encephalitis.
Degenerative Cervical Myelopathy: A Spectrum of Related Disorders Affecting the Aging Spine.
[Blood and cerebrospinal fluid test in multiple sclerosis].
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis.
Correlation of the VEMP score, ambulation and upper extremity function in clinically isolated syndrome.
Anatomical and functional retinal changes in multiple sclerosis.
The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.
Zoledronic acid improves bone mineral density in paediatric spinal cord injury.
Pages
« first
‹ previous
…
564
565
566
567
568
569
570
571
572
…
next ›
last »